EUVIMEDEUVIMED entdecken
Open Access

Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells

Hua Mao iD, Claire M Li, Bing Sun, Christopher S Ward iD, Alan R Waich-Cohen iD, Ivan O Rosas iD, Howard J Huang iD, Harry Karmouty-Quintana iD, Liang Xie, Lavannya M Pandit iD, Xinchun Pi iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.124.322189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Hua Mao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiovascular Research (H.M., C.M.L., B.S., L.X., X.P.), Baylor College of Medicine, Houston, TX. Hauptthemen laut MEDLINE: Myocytes, Smooth Muscle, Low Density Lipoprotein Receptor-Related Protein-1, Adaptor Proteins, Signal Transducing, Pulmonary Artery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: BMPER (bone morphogenetic protein–binding endothelial regulator) is a secreted protein that is highly expressed in endothelial cells. It regulates the BMP (bone morphogenetic protein) pathway during vascular development and adulthood. Mutations in the BMP pathway are recognized as risk factors for pulmonary arterial hypertension group 1 pulmonary hypertension (PH). However, the roles of BMPER in pulmonary arterial hypertension remain unknown. METHODS: We assessed BMPER expression in Group 1 pulmonary arterial hypertension patient samples and examined its role in vascular remodeling using in vivo and in vitro approaches. RESULTS: BMPER level was elevated in pulmonary arterial hypertension lungs and significantly associated with pulmonary vascular resistance, but was not increased in patient plasma. Global and endothelial cell–specific depletion of BMPER in a mouse model of hypoxia-induced PH displayed attenuation in pulmonary artery smooth muscle cell proliferation, a hallmark of pulmonary vascular remodeling, and reduced right ventricular pressures. Conversely, adeno-associated virus–assisted BMPER overexpression targeted to the pulmonary endothelium led to the spontaneous development of PH. Mechanistically, BMPER promoted YAP (yes-associated protein 1) activation through the release of YAP sequestration by LRP1 (low-density lipoprotein receptor–related protein 1), a BMPER endocytic receptor, in the membrane of pulmonary artery smooth muscle cells. Moreover, the protective effect of BMPER depletion can be reversed by simultaneous depletion of LRP1 in mice with hypoxia-induced PH. CONCLUSIONS: Collectively, these results implicate secreted BMPER as a discrete regulator for pulmonary vascular remodeling and suggest its inhibition as a new potential therapeutic strategy against PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, Smooth MuscleLow Density Lipoprotein Receptor-Related Protein-1Adaptor Proteins, Signal TransducingPulmonary ArteryMuscle, Smooth, VascularHypertension, PulmonaryPulmonary Arterial HypertensionAnimalsVascular RemodelingDisease Models, AnimalYAP-Signaling ProteinsHumansCell ProliferationSignal TransductionCells, CulturedCell Cycle ProteinsMice, Inbred C57BLMaleMiceArterial PressureTranscription FactorsMice, KnockoutVentricular Function, Right

Stichwörter der Autor:innen

cell proliferationendothelial cellshypertension, pulmonaryhypoxiavascular remodeling

Substanzen

Low Density Lipoprotein Receptor-Related Protein-1Adaptor Proteins, Signal TransducingYAP-Signaling ProteinsYap1 protein, mouseLrp1 protein, mouseCell Cycle ProteinsYAP1 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Department of Medicine, Cardiovascular Research (H.M., C.M.L., B.S., L.X., X.P.), Baylor College of Medicine, Houston, TX.
  • Cardiovascular Research Institute (H.M., C.M.L., B.S., L.X., X.P.), Baylor College of Medicine, Houston, TX.
  • Department of Molecular Physiology and Biophysics, Advanced Technology Cores (C.S.W.), Baylor College of Medicine, Houston, TX.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine (A.R.W.-C., I.O.R.), Baylor College of Medicine, Houston, TX.
  • Houston Methodist DeBakey Transplant Center, Houston Methodist Hospital, TX (H.J.H.).
  • Department of Biochemistry and Molecular Biology (H.K.-Q.), McGovern Medical School at The University of Texas Health Science Center at Houston.

ORCID-Profile: Hua Mao, Christopher S Ward, Alan R Waich-Cohen, Ivan O Rosas, Howard J Huang, Harry Karmouty-Quintana, Lavannya M Pandit, Xinchun Pi

Förderung

  • BLRD VA
  • NHLBI NIH HHS
  • NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Mao, H., Li, C. M., Sun, B., Ward, C. S., Waich-Cohen, A. R., Rosas, I. O., Huang, H. J., Karmouty-Quintana, H., Xie, L., Pandit, L. M., & Pi, X. (2025). Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.322189

Vancouver

Mao H, Li CM, Sun B, Ward CS, Waich-Cohen AR, Rosas IO, et al. Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.322189

BibTeX
@article{Mao2025,
  author = {Mao, Hua and Li, Claire M and Sun, Bing and Ward, Christopher S and Waich-Cohen, Alan R and Rosas, Ivan O and Huang, Howard J and Karmouty-Quintana, Harry and Xie, Liang and Pandit, Lavannya M and Pi, Xinchun},
  title = {Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.124.322189}
}
Kostenlos starten →